• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    15 May 2025
    Insider Trades
    1668.40
    -1.26%
    JB Chemicals Q4 Results Review: Dolat Capital Maintains 'Buy' Post Inline Earnings, Sees 27% Upside
    JB Chemicals Q4 Results Review: Dolat Capital Maintains 'Buy' Post Inline Earnings, Sees 27% Upside
    NDTV Profit
    Dolat Capital maintains Buy' rating on JB Chemicals with a revised target price of Rs 2,081 at 32 times FY27 P/E adjusted for ESOP and amortization.
    Copy LinkShare onShare on Share on Share on
    J B Chemicals & Phar.. has an average target of 2030.00 from 2 brokers.
    logo
    Piramal Pharma Ltd.
    15 May 2025
    198.47
    -0.29%
    Piramal Pharma expects single-digit growth in FY26 amid uncertainties
    Business Standard
    PPL projects a muted FY26 due to global headwinds but aims to double its India consumer health business turnover to Rs 2,000 crore by FY30 through scale and expansion
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. is trading below its 100 day SMA of 200.2
    logo
    Lupin Ltd.
    15 May 2025
    1973.60
    -0.39%
    Lupin clocks 113% growth in Q4 net profit at 782 crore
    Business Line
    Nilesh Gupta, Managing Director, Lupin, said, the last quarter and the year ended on a strong note.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    Lupin Share Price Gains After Q4 Profit Surge, Revenue Rise
    NDTV Profit | 15 May 2025 2 more
    Lupin Q4 results: Net profit zooms by 112% to 782 cr, revenue up 14%
    Business Standard | 15 May 2025
    Lupin Q4 Results: Profit More Than Doubles, Beats Estimates
    NDTV Profit | 14 May 2025
    logo
    Sai Life Science Ltd.
    15 May 2025
    882.60
    -0.51%
    Sai Lifesciences Gets Target Price Hike From Morgan Stanley As Growth Outpaces Industry
    Sai Lifesciences Gets Target Price Hike From Morgan Stanley As Growth Outpaces Industry
    NDTV Profit
    Sai Lifesciences was able to grow its contract research business 26% year-on-year in financial year 2025 even as funding in the biotechnology environment softened.
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.66% of shares in last quarter. Total pledge stands at 0.01% of promoter holdings
    logo
    Mankind Pharma Ltd.
    14 May 2025
    2448.00
    0.34%
    Mankind Pharma Gets Rs 342-Crore Additional Tax Demand From I-T Authority
    Mankind Pharma Gets Rs 342-Crore Additional Tax Demand From I-T Authority
    NDTV Profit
    Mankind Pharma believes that "the demands under the orders are not tenable in law".
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    14 May 2025
    Insider Trades
    1668.40
    -1.26%
    JB Chemicals & Pharmaceuticals Q4 Results: Profit, Revenue Meet Estimates
    JB Chemicals & Pharmaceuticals Q4 Results: Profit, Revenue Meet Estimates
    NDTV Profit
    The international business revenue saw a growth of 9%, reaching Rs 430 crore.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 319 to 311 in Jun 2025 qtr
    logo
    Cipla Ltd.
    14 May 2025
    1517.70
    0.31%
    Cipla Health launches mobile application Nicotex Begin' for smokers
    Business Line
    The mobile application programme is expected to help curb a consumer's desire to smoke again
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
    logo
    Sanofi Consumer Healthcare India Ltd.
    14 May 2025
    4797.60
    1.03%
    Sanofi India Q4 results: Profit falls 12.5% to 119.5 cr, revenue up 4.9%
    Business Standard
    Sanofi India's Q4FY25 profit declined 12.5% Y-o-Y to 119.5 crore, while revenue rose 4.9%; operating profit improved 27% on better efficiency, says CFO
    Copy LinkShare onShare on Share on Share on
    Sanofi Consumer Healthcare India Ltd. is trading below all available SMAs
    logo
    Cipla Ltd.
    14 May 2025
    1517.70
    0.31%
    Cipla shares at 1,800 or 1,465? Analysts divided on pharma stock post Q4
    Business Standard
    Cipla share price today: Cipla shares today declined 2.9 per cent intraday to hit a low of 1,474.1 per share
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. is trading below its 30 day SMA of 1555.1
    Cipla Q4 Results Review: Dolat Capital Maintains 'Add' Rating, Hikes Target Price Here's Why
    NDTV Profit | 14 May 2025 9 more
    Cipla Q4 Review: FY26 Forecast Appears Conservative, India Business Drive Optimism: Analysts
    NDTV Profit | 14 May 2025
    Cipla Q4FY25 results: Net profit zooms 30% to 1,221 cr, revenue up 9%
    Business Standard | 13 May 2025
    With several moving parts, next six months will be a challenge, says Cipla Chief Umang Vohra
    Business Line | 13 May 2025
    Cipla Sees Minimal Impact From Trump Order On Cutting US Drug Prices
    NDTV Profit | 13 May 2025
    US govt order to have nil impact on Indian pharma players, says Cipla
    Business Standard | 13 May 2025
    US government order to have nil impact on Indian pharma players, says Cipla
    Business Line | 13 May 2025
    Cipla Declares Final Dividend Of Rs 16
    NDTV Profit | 13 May 2025
    Cipla Q4 result: Profit rises 30% to 1,222 cr; special dividend declared
    Business Standard | 13 May 2025
    Cipla Q4 Results: Profit Rises 30%, Beats Estimates
    NDTV Profit | 13 May 2025
    logo
    GlaxoSmithKline Pharmaceuticals Ltd.
    14 May 2025
    2745.80
    1.80%
    Here's why GSK Pharma share price was buzzing in trade on Wednesday, May 14
    Business Standard
    The up move in the GSK Pharma share price came after the company posted a healthy March quarter of financial year 2025 (Q4FY25) results.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 340 to 390 in Jun 2025 qtr.
    GlaxoSmithKline Pharma Q4 Results: Profit Up 36% At Rs 263 Crore
    NDTV Profit | 13 May 2025 1 more
    GSK Pharma Q4 profit rises 35% to 263 crore on strong brand growth
    Business Standard | 13 May 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • DSM Fresh Foods
    • Greenleaf Envirotech
    • NSB BPO Solutions
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)